Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q1 2023

Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.

Institution overview
Positions
54
−3 vs. Q4 2022
Portfolio value
$2.35B
+$57.8M (+2.5%) vs. Q4 2022
Filed
May 15, 2023
SEC
Holdings of Deep Track Capital, LP in Q1 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
JAZZJazz Pharmaceuticals plcSHS USD1,200,000$175.6M7.5%+326,447+37.4%AddedHistory
ISEEIVERIC bio, Inc.COM6,500,000$158.1M6.7%−1,378,119−17.5%ReducedHistory
TVTXTravere Therapeutics, Inc.COM6,147,268$138.3M5.9%+1,565,268+34.2%AddedHistory
IMVTImmunovant, Inc.COM7,432,717$115.3M4.9%−2,277,283−23.5%ReducedHistory
INSMINSMED IncCOM PAR $.016,500,000$110.8M4.7%+2,235,708+52.4%AddedHistory
IONSIonis Pharmaceuticals IncCOM2,834,069$101.3M4.3%+1,628,296+135.0%AddedHistory
ITCIIntra-Cellular Therapies, Inc.COM1,700,000$92.1M3.9%+1,700,000NewHistory
PLRXPliant Therapeutics, Inc.COM3,422,057$91.0M3.9%+1,689,111+97.5%AddedHistory
ALKSAlkermes plc.SHS3,000,000$84.6M3.6%+3,000,000NewHistory
SWTXSpringWorks Therapeutics, Inc.COM3,100,000$79.8M3.4%−9,886−0.3%ReducedHistory
KDNYChinook Therapeutics, Inc.COM3,000,000$69.5M3.0%00.0%UnchangedHistory
RETAReata Pharmaceuticals IncCL A729,000$66.3M2.8%+729,000NewHistory
VRNAVerona Pharma plcSPONSORED ADS3,187,415$64.0M2.7%00.0%UnchangedHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS2,646,782$63.0M2.7%+2,646,782NewHistory
DVAXDynavax Technologies CorpCOM NEW6,350,000$62.3M2.6%+4,022,049+172.8%AddedHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS2,819,045$60.0M2.5%00.0%UnchangedHistory
GERNGeron CorpCOM26,867,479$58.3M2.5%+19,452,786+262.4%AddedHistory
BIIBBiogen Inc.COM200,000$55.6M2.4%−100,000−33.3%ReducedHistory
DICEDICE Therapeutics, Inc.COM1,600,000$45.8M1.9%−134,143−7.7%ReducedHistory
AGENAgenus IncCOM NEW30,000,000$45.6M1.9%+3,000,000+11.1%AddedHistory
PACBPacific Biosciences of California, Inc.COM3,504,390$40.6M1.7%+3,504,390NewHistory
FDMT4D Molecular Therapeutics, Inc.COM2,278,107$39.2M1.7%−378,794−14.3%ReducedHistory
BEAMBeam Therapeutics Inc.COM1,250,000$38.3M1.6%+83,527+7.2%AddedHistory
EXELExelixis, Inc.COM1,931,874$37.5M1.6%+1,931,874NewHistory
VRDNViridian Therapeutics, Inc.COM1,230,259$31.3M1.3%−540,895−30.5%ReducedHistory
AUTLAutolus Therapeutics plcSPON ADS15,000,000$27.6M1.2%00.0%UnchangedHistory
ETNB89bio, Inc.COM1,800,000$27.4M1.2%−2,050,000−53.2%ReducedHistory
DYNDyne Therapeutics, Inc.COM2,334,633$26.9M1.1%−349,567−13.0%ReducedHistory
RPTXRepare Therapeutics Inc.COM2,727,606$26.8M1.1%00.0%UnchangedHistory
NRIXNurix Therapeutics, Inc.COM2,997,830$26.6M1.1%+731,261+32.3%AddedHistory
NTLAIntellia Therapeutics, Inc.COM704,533$26.3M1.1%+4,533+0.6%AddedHistory
ATXSAstria Therapeutics, Inc.COM1,816,531$24.2M1.0%00.0%UnchangedHistory
DCPHDeciphera Pharmaceuticals, Inc.COM1,363,201$21.1M0.9%+1,363,201NewHistory
EWTXEdgewise Therapeutics, Inc.COM3,068,259$20.5M0.9%−306,135−9.1%ReducedHistory
VIGLVigil Neuroscience, Inc.COM2,025,137$19.8M0.8%−79,037−3.8%ReducedHistory
INZYInozyme Pharma, Inc.COM3,250,000$18.6M0.8%00.0%UnchangedHistory
QUREuniQure N.V.SHS865,767$17.4M0.7%+865,767NewHistory
PNTPOINT Biopharma Global Inc.COM2,345,073$17.0M0.7%+2,345,073NewHistory
ABOSAcumen Pharmaceuticals, Inc.COM3,952,000$16.0M0.7%00.0%UnchangedHistory
ALLKAllakos Inc.COM3,585,000$16.0M0.7%−1,314,179−26.8%ReducedHistory
ACRSAclaris Therapeutics, Inc.COM1,708,971$13.8M0.6%+1,708,971NewHistory
NUVBNuvation Bio Inc.COM CL A7,720,688$12.8M0.5%−500,500−6.1%ReducedHistory
SLNSilence Therapeutics plcADS1,951,580$12.1M0.5%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM571,233$10.5M0.4%−733,707−56.2%ReducedHistory
JNCEJounce Therapeutics, Inc.COM4,259,653$7.88M0.3%00.0%UnchangedHistory
RLMDRelmada Therapeutics, Inc.COM2,837,818$6.41M0.3%00.0%UnchangedHistory
ORTXOrchard Therapeutics plcSPON ADS NEW1,166,670$6.27M0.3%+1,166,670NewHistory
HRTXHeron Therapeutics, Inc.COM3,234,722$4.88M0.2%−3,262,254−50.2%ReducedHistory
NKTXNkarta, Inc.COM1,354,200$4.81M0.2%00.0%UnchangedHistory
GHRSGH Research PLCORDINARY SHARES499,400$3.99M0.2%00.0%UnchangedHistory
IMUXImmunic, Inc.COM2,524,242$3.76M0.2%+2,524,242NewHistory
TSVT2seventy bio, Inc.COMMON STOCK350,000$3.57M0.2%+350,000NewHistory
IPSCCentury Therapeutics, Inc.COM1,022,892$3.55M0.2%+327,047+47.0%AddedHistory
NKTRNektar TherapeuticsCOM1,743,248$1.23M0.1%+1,743,248NewHistory

Options (4)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q1 2023
SecurityClassPutsCalls
SGENSeagen Inc.COM$44.1M–
ARGXArgenx SESPONSORED ADR$37.3M–
IMGNImmunoGen, Inc.COM$1.64M–
ETNB89bio, Inc.COM$67.0K–

Sold out since Q4 2022 (17)

Positions held at the end of Q4 2022 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q4 2022
SecurityClassShares in Q4 2022Value in Q4 2022% of portfolio in Q4 2022History
ASNDAscendis Pharma A/SSPONSORED ADR700,000$85.5M3.7%History
SRPTSarepta Therapeutics, Inc.COM528,244$68.4M3.0%History
HZNPHorizon Therapeutics Public Ltd CoSHS500,000$56.9M2.5%History
ALBOAlbireo Pharma, Inc.COM1,704,000$36.8M1.6%History
ESPREsperion Therapeutics, Inc.COM4,000,000$24.9M1.1%History
BMRNBiomarin Pharmaceutical IncCOM189,800$19.6M0.9%History
CRNXCrinetics Pharmaceuticals, Inc.COM1,048,829$19.2M0.8%History
SNDXSyndax Pharmaceuticals IncCOM500,000$12.7M0.6%History
PTGXProtagonist Therapeutics, IncCOM871,493$9.51M0.4%History
Avidity Biosciences, Inc.05370A108COM300,000$6.66M0.3%–
VKTXViking Therapeutics, Inc.COM610,083$5.73M0.2%History
FULCFulcrum Therapeutics, Inc.COM768,607$5.60M0.2%History
ASMBAssembly Biosciences, Inc.COM1,833,437$2.38M0.1%History
THRDThird Harmonic Bio, Inc.COM445,572$1.92M0.1%History
AUPHAurinia Pharmaceuticals Inc.COM324,238$1.40M0.1%History
DNTHDianthus Therapeutics, Inc.COM3,000,000$1.19M0.1%History
HOOKHOOKIPA Pharma Inc.COM1,240,369$1.00M<0.1%History